Production of omega 3 long chain polyunsaturated fatty acids in oilseed crops by a thraustochytrid pufa synthase
US-2018282711-A1 · Oct 4, 2018 · US
US10538772B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10538772-B2 |
| Application number | US-201615371410-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 7, 2016 |
| Priority date | Mar 19, 2009 |
| Publication date | Jan 21, 2020 |
| Grant date | Jan 21, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention is directed to isolated nucleic acid molecules and polypeptides of thraustochytrid polyunsaturated fatty acid (PUFA) synthases involved in the production of PUFAs, including PUFAs enriched in docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or a combination thereof. The present invention is directed to vectors and host cells comprising the nucleic acid molecules, polypeptides encoded by the nucleic acid molecules, compositions comprising the nucleic acid molecules or polypeptides, and methods of making and uses thereof.
Opening claim text (preview).
What is claimed is: 1. An recombinant nucleic acid molecule comprising a polynucleotide sequence encoding a polypeptide and a transcription control sequence, wherein the polypeptide comprises an amino acid sequence at least 90% identical to SEQ ID NO:8, wherein the polypeptide comprises KS activity, said polynucleotide sequence is heterologous to said transcription control sequence. 2. The recombinant nucleic acid molecule of claim 1 , wherein the polynucleotide sequence is at least 95% identical to SEQ ID NO:8. 3. A host cell that expresses any one of the nucleic acid molecule of claim 1 , wherein said nucleic acid molecule is heterologous to the host cell, and wherein said host cell is not a human cell. 4. The host cell of claim 3 , wherein the host cell is selected from the group consisting of a plant cell, a microbial cell, and an isolated animal cell. 5. The host cell of claim 4 , wherein the microbial cell is a thraustochytrid, excluding Thraustochytrium sp. ATCC PTA-9695. 6. The host cell of claim 5 , wherein the thraustochytrid is a Schizochytrium or a Thraustochytrium. 7. The host cell of claim 4 , wherein the plant cell is selected from the group consisting of: canola, soybean, rapeseed, linseed/flax, maize, safflower, sunflower, tobacco, Arabidopsis thaliana, Brazil nut, castor bean, coconut, coriander, cotton, groundnut, jojoba, mustard, oil palm, olive, rice, squash, barley, wheat, and duckweed. 8. A method to produce at least one PUFA, comprising: expressing a PUFA synthase gene in a host cell under conditions effective to produce PUFA, wherein the PUFA synthase gene comprises any one of the nucleic acid molecule of claim 1 , and wherein at least one PUFA is produced, and wherein the nucleic acid molecule is heterologous to the host cell. 9. A method to produce lipids enriched for DHA, EPA, or a combination thereof, comprising: expressing a PUFA synthase gene in a host cell under conditions effective to produce lipids, wherein the PUFA synthase gene comprises the nucleic acid molecule of claim 1 , and wherein lipids enriched with DHA, EPA, or a combination thereof are produced. 10. A method of increasing production of DHA, EPA, or a combination thereof in an organism having PUFA synthase activity, comprising: expressing the recombinant nucleic acid molecule of claim 1 in the organism under conditions effective to produce DHA, EPA, or a combination thereof, wherein said nucleic acid molecule is heterologous to the host organism, and wherein the PUFA synthase activity replaces an inactive or deleted activity, introduces a new activity, or enhances an existing activity in the organism, and wherein production of DHA, EPA, or a combination thereof in the organism is increased.
Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00) · CPC title
Hydro-lyases (4.2.1) · CPC title
Genes encoding for enzymes or proenzymes · CPC title
[Acyl-carrier-protein] S-malonyltransferase (2.3.1.39) · CPC title
with NAD+ or NADP+ as acceptor (1.1.1) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.